Clinical trials for Amyloidosis
24 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 3
Amyloidosis
#NCT07207811
#2024-518899-31-00
Required histologic types
Other
Required organ involvement status
Presence
Required organ involvements
Cardiac
19 recruiting sites
Novo Nordisk A/S
Phase 3
Amyloidosis
#NCT06128629
#2023-507220-23-00
Required histologic types
Other
Required organ involvement status
Presence
Required organ involvements
Cardiac
5 recruiting sites
Intellia Therapeutics
Phase 3
Amyloidosis
#NCT06563895
#2024-513547-82-00
Required histologic types
Other
Required genetic anomalies
Other mutation
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
Required organ involvement status
Absence
5 recruiting sites
Eidos Therapeutics, a BridgeBio company
Phase 3
Amyloidosis
#NCT07052903
#2024-519917-72-00
Required histologic types
Other
Required organ involvement status
Presence
Required organ involvements
Cardiac
15 recruiting sites
Alnylam Pharmaceuticals
Phase 3
Amyloidosis
#NCT07223203
#2025-522544-40-00
Required histologic types
Other
Required organ involvement status
Presence
Required organ involvements
Neurological
3 recruiting sites
Alnylam Pharmaceuticals
Phase 2
Amyloidosis
#NCT06649695
#2024-519191-90-00
Required histologic types
AL Amyloidosis
Required number of previous lines of therapy
1
2
3 or more
Required previous treatments
Chemotherapy
Monoclonal antibodies
Proteasome inhibitor
Required Mayo Clinic stages
Stade I
Stade II
Stade IIIA
Excluded previous treatments
Systemic Treatment-Naive
1 recruiting site
European Myeloma Network B.V.
Phase 1 / Phase 2
Amyloidosis
#NCT06158854
Required histologic types
AL Amyloidosis
Required number of previous lines of therapy
1
2
3 or more
Required previous treatments
Monoclonal antibodies
Proteasome inhibitor
Required organ involvement status
Presence
Required Mayo Clinic stages
Stade I
Stade II
Stade IIIA
Excluded previous treatments
Systemic Treatment-Naive
2 recruiting sites
Abbvie
Phase 1
Amyloidosis
#NCT05652335
#2022-001465-12
Cohorte Amlyose AL précédemment traitée
Required histologic types
AL Amyloidosis
Required number of previous lines of therapy
1
2
3 or more
Required organ involvement status
Presence
Excluded previous treatments
Systemic Treatment-Naive
3 recruiting sites
Janssen
Phase 1
1 recruiting site